MAX 最新10-Q变化
将 MAX 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-07-29 与上一份 10-Q · 2026-04-29
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +65 | −29 | ~48 | 29 |
| 市场风险(第3项) | 文字有新增/删除 | 0 | 0 | ~2 | 54 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~2 | 54 |
| 法律诉讼 | 文字有新增/删除 | 0 | 0 | ~2 | 54 |
| 风险因素 | 文字有新增/删除 | 0 | 0 | ~2 | 54 |
| 其他信息 | 文字有新增/删除 | 0 | 0 | ~2 | 54 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-07-29
Net income for the three months ended June 30, 2026 was $41.8 million, compared with a net loss of $22.5 million for the three months ended June 30, 2025, due primarily to a $37.7 million gain on extinguishment of a portion of the liability under the tax receivables agreement resulting from our repu…
On June 25, 2026, we entered into an Assignment, Assumption and Termination Agreement with Insignia, pursuant to which we purchased Insignia's interest in the TRA for $31.0 million in cash ("TRA Settlement"). As of March 31, 2026, our estimated future liability under the TRA was $123.4 million, of w…
Our results are subject to fluctuations as a result of seasonality. In particular, our P&C insurance vertical is typically characterized by seasonal strength in our quarters ending March 31 due to a greater supply of Consumer Referrals and higher customer acquisition budgets during the start of the …
with a material increase in consumer search volume for health products and a related increase in buyer customer acquisition budgets.
Consumer Referrals transacted, which is a negotiated percentage of the Transaction Value of such transactions. We do not make any payments to Supply Partners in our Private Marketplace transactions.
相对上期删除的文字 · 来源:10-Q · 2026-04-29
Net income for the three months ended March 31, 2026 was $14.0 million, compared with a net loss of $2.3 million for the three months ended March 31, 2025, due primarily to an increase in gross profit. In addition, in the three months ended March 31, 2025 we incurred a write-off of $13.4 million of …
On March 25, 2026, we entered into an amendment and restatement agreement to our Existing Credit Agreement, which provides for a new senior secured term loan facility in an aggregate principal amount of $150.0 million and a new senior secured revolving credit facility with commitments in an aggregat…
On February 3, 2026, we entered into a lease agreement for a new corporate headquarters comprised of approximately 21,000 square feet of office space located in Los Angeles, CA. The initial term of such lease is 65 months commencing upon the later of November 1, 2026 and substantial completion of th…
On February 18, 2026, our Board of Directors authorized an increase in the previously approved Repurchase Program by $50.0 million, to a total of up to $100.0 million ("Repurchase Program"). As of March 31, 2026, we had repurchased 3,173,374 shares of Class A common stock for aggregate consideration…
increased their spending in our marketplaces. During the first quarter of 2026, the ongoing geopolitical conflict in the Middle East has caused significant increases in energy prices and disruption in supply chains for certain products. In the event that such war escalates or continues for an extend…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议